What sector is veev in?

life sciences industry
Veeva Systems Inc (NYSE:VEEV) Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry.

Is veeva a good company to work for?

Veeva Systems – Great place to work! They exceed expectations by enabling employees with a “work anywhere” remote-working environment and still empower a positive company culture. Overall, the environment of work-life balance leans toward working longer hours.

Is veeva a public company?

On February 1, 2021 Veeva Systems officially became a Public Benefit Corporation (PBC). With this move, it becomes the first technology company supporting life sciences to transition to a PBC and is also the first publicly traded corporation in any industry to make that move.

What is veeva Incorporated?

Veeva Systems Inc. provides cloud-based business services. The Company offers enterprise applications, multichannel platform, customer relationship, and content management solutions. Veeva Systems serves customers worldwide.

Is veeva a good stock to buy?

Yet Veeva is consistently profitable by both GAAP and non-GAAP measures. It spent less than 13% of its revenue on stock-based compensation expenses last year, and its GAAP net income increased 26% to $380 million, which was only slightly lower than its non-GAAP profit of $473 million.

What do Veeva Systems do?

The Industry Cloud for Life Sciences Our industry cloud solutions provide data, software, services and an extensive ecosystem of partners to support your most critical functions from R&D through commercial. Veeva helps companies of all sizes bring products to market faster and more efficiently, and maintain compliance.

Does veeva pay well?

The average estimated annual salary, including base and bonus, at Veeva Systems is $139,447, or $67 per hour, while the estimated median salary is $142,241, or $68 per hour. Salaries contributed from Veeva Systems employees include job titles like Principal Engineer, Lead Engineer, Developer, and Director of Product.

Is veeva owned by Salesforce?

Built on the Salesforce1 Platform, Veeva CRM is part of Veeva’s Commercial Suite for life sciences, which delivers the accurate customer data and compliant content required to enable more effective customer engagement across multiple communication channels.

Who are veeva competitors?

Veeva Systems’s top competitors include BioClinica, Upland Software, Oracle, IQVIA, Medidata and Open Text.

Where is veeva located?

Pleasanton, California
Headquartered in Pleasanton, California, Veeva has 15+ offices spanning five continents.

Is veeva a buy or sell?

Veeva Systems has received a consensus rating of Buy. The company’s average rating score is 2.70, and is based on 15 buy ratings, 4 hold ratings, and 1 sell rating.

Is veeva overvalued?

In summary, Veeva Systems (NYSE:VEEV, 30-year Financials) stock is believed to be modestly overvalued. The company’s financial condition is fair and its profitability is strong. Its growth ranks better than 82% of the companies in the industry of Healthcare Providers & Services.

Show less

Veeva Systems crushed Wall Street’s first-quarter estimates late Thursday, leading VEEV stock to surge closer to a breakout on Friday. Below, we’ll look at what salesforce.com (NYSE: CRM) and Veeva Systems (NYSE: VEEV) had to say about their recent business activity. Salesforce’s first-quarter report looked solid.

What kind of software does Veeva Systems use?

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry.

Who are the founding members of Veeva Systems?

The company’s customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. Veeva Systems was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Who are the speakers at the Veeva summit?

Veeva Systems (NYSE: VEEV) today announced that leaders from Boehringer Ingelheim, GSK, and UCB will be among the featured keynote speakers at the 2021 Veeva Commercial & Medical North America Summit Connect on June 10, 2021. They will share the innovative digital approaches and best practices helping their companies maximize commercial impact.